{
    "organizations": [],
    "uuid": "0907b3e22dc4ddddf67fc2d076c63aa2fe76fd5f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncosec-expands-relationship-with/brief-oncosec-expands-relationship-with-merck-for-combination-of-immunopulse-il-12-and-keytruda-idUSB8N1LI03M",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncosec Expands Relationship With Merck For Combination Of Immunopulse Il-12 And Keytruda",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - OncoSec Medical Inc:\n* ONCOSEC EXPANDS RELATIONSHIP WITH MERCK, ANNOUNCES CLINICAL COLLABORATION TO EVALUATE COMBINATION OF IMMUNOPULSE IL-12 AND KEYTRUDA FOR TRIPLE NEGATIVE BREAST CANCER\n* ONCOSEC MEDICAL - PLANNED TRIAL WILL EVALUATE SAFETY, EFFICACY OF COMBINATION IN CERTAIN PATIENTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC TNBC\n* ONCOSEC MEDICAL SAYS UNDER COLLABORATION AGREEMENT, ONCOSEC WILL SPONSOR, FUND STUDY AND MERCK WILL PROVIDE KEYTRUDA\n* ONCOSEC MEDICAL SAYS ADDITIONAL DETAILS OF THE COLLABORATION WERE NOT DISCLOSED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T19:35:00.000+03:00",
    "crawled": "2018-05-09T12:30:56.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oncosec",
        "medical",
        "inc",
        "oncosec",
        "expands",
        "relationship",
        "merck",
        "announces",
        "clinical",
        "collaboration",
        "evaluate",
        "combination",
        "immunopulse",
        "keytruda",
        "triple",
        "negative",
        "breast",
        "cancer",
        "oncosec",
        "medical",
        "planned",
        "trial",
        "evaluate",
        "safety",
        "efficacy",
        "combination",
        "certain",
        "patient",
        "inoperable",
        "locally",
        "advanced",
        "metastatic",
        "tnbc",
        "oncosec",
        "medical",
        "say",
        "collaboration",
        "agreement",
        "oncosec",
        "sponsor",
        "fund",
        "study",
        "merck",
        "provide",
        "keytruda",
        "oncosec",
        "medical",
        "say",
        "additional",
        "detail",
        "collaboration",
        "disclosed",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}